Neuroprogression and Cognitive Functioning in Bipolar Disorder: A Systematic Review

Current Psychiatry Reports

Volumn 17, Issue 9, 2015, Pages

  Cardoso, Taiane ^a,b   Bauer, Isabelle E ^a   Meyer, Thomas D ^a   Kapczinski, Flavio ^a   Soares, Jair C ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b CATHOLIC UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

Aging; Bipolar disorder; Cognition; Neuroprogression

Indexed keywords

AGING; ATTENTION; BIPOLAR I DISORDER; BIPOLAR II DISORDER; COGNITION; COGNITIVE FLEXIBILITY; COMORBIDITY; CROSS-SECTIONAL STUDY; DETERIORATION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DSM-IV; EMOTION; EXECUTIVE FUNCTION; FOLLOW UP; HOSPITALIZATION; HUMAN; INTELLECTUAL IMPAIRMENT; LEARNING; LONGITUDINAL STUDY; MAJOR DEPRESSION; MEMORY; MOOD; NEUROPROGRESSION; NEUROPSYCHOLOGICAL TEST; NONHUMAN; PSYCHOMOTOR PERFORMANCE; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SUBSTANCE ABUSE; SYSTEMATIC REVIEW; VERBAL MEMORY; AFFECT; BIPOLAR DISORDER; COGNITIVE AGING; EPIDEMIOLOGY; METABOLISM; METHODOLOGY; MILD COGNITIVE IMPAIRMENT; PATHOPHYSIOLOGY; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA;

AFFECT; ATTENTION; BIPOLAR DISORDER; COGNITION; COGNITIVE AGING; CONFOUNDING FACTORS (EPIDEMIOLOGY); CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; HOSPITALIZATION; HUMANS; LONGITUDINAL STUDIES; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; RESEARCH DESIGN;

EID: 84938869260     PISSN: 15233812     EISSN: 15351645     Source Type: Journal    
DOI: 10.1007/s11920-015-0605-x     Document Type: Review

References (74)

1. Bora E, Yucel M, Pantelis C. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord. 2009;113(1):1–20.
2. Glahn DC et al. The neurocognitive signature of psychotic bipolar disorder. Biol Psychiatry. 2007;62(8):910–6.
3. Quraishi S, Frangou S. Neuropsychology of bipolar disorder: a review. J Affect Disord. 2002;72(3):209.
4. Martínez-Arán A et al. Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disord. 2004;6(3):224–32.
5. Sanches M, et al. The management of cognitive impairment in bipolar disorder: current status and perspectives. Am J Ther. 2014.
6. Dixon T et al. Effect of symptoms on executive function in bipolar illness. Psychol Med. 2004;34(5):811–21.
7. Basso MR et al. Neuropsychological impairment among manic, depressed, and mixed-episode inpatients with bipolar disorder. Neuropsychology. 2002;16(1):84.
8. Martínez-Arán A et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatr. 2004;161(2):262–70.
9. Albus M et al. Contrasts in neuropsychological test profile between patients with first-eoisode schizophienia and first-episohe affective disorders. Acta Psychiatr Scand. 1996;94(2):87–93.
10. Martinez-Aran A et al. Do cognitive complaints in euthymic bipolar patients reflect objective cognitive impairment? Psychother Psychosom. 2005;74(5):295–302.
11. Gruber S et al. Stability and course of neuropsychological deficits in manic and depressed bipolar patients compared to patients with major depression. J Affect Disord. 2007;104(1–3):61–71.
12. Sweeney JA, Kmiec JA, Kupfer DJ. Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery. Biol Psychiatry. 2000;48(7):674–84.
13. Kapczinski F, Streb LG. Neuroprogression and staging in psychiatry: historical considerations. Rev Bras Psiquiatr. 2014;36(3):187–8.
14. Fries GR et al. Staging and neuroprogression in bipolar disorder. Curr Psychiatry Rep. 2012;14(6):667–75.
15. Berk M et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev. 2011;35(3):804–17.
16. Berk M et al. From neuroprogression to neuroprotection: implications for clinical care. Med J Aust. 2010;193(4 Suppl):S36–40.
17. Kapczinski F et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev. 2008;32(4):675–92.
18. Bauer IE et al. Inflammatory mediators of cognitive impairment in bipolar disorder. J Psychiatr Res. 2014;56:18–27.
19. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(6):e1000097.
20. Kapczinski F, Dias V, Kauer-Sant’Anna M, Frey BN, Grassi-Oliveira R, Colom F, et al. Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother. 2009;9(6):957–66.
21. Post RM, Fleming J, Kapczinski F. Neurobiological correlates of illness progression in the recurrent affective disorders. J Psychiatr Res. 2012;46(5):561–73.
22. Bora E et al. The effect of previous psychotic mood episodes on cognitive impairment in euthymic bipolar patients. Bipolar Disord. 2007;9(5):468–77.
23. Cheung EYW et al. Cognitive performance is impaired in euthymic Chinese patients with bipolar 1 disorder. J Affect Disord. 2013;151(1):156–63.
24. Frangou S et al. The maudsley bipolar disorder project: executive dysfunction in bipolar disorder I and its clinical correlates. Biol Psychiatry. 2005;58(11):859–64.
25. Delaloye C et al. Longitudinal analysis of cognitive performances and structural brain changes in late-life bipolar disorder. Int J Geriatr Psychiatry. 2011;26(12):1309–18.
26. Mora E et al. Persistence of cognitive impairment and its negative impact on psychosocial functioning in lithium-treated, euthymic bipolar patients: a 6-year follow-up study. Psychol Med. 2013;43(6):1187–96.
27. Torrent C et al. Long-term outcome of cognitive impairment in bipolar disorder. J Clin Psychiatry. 2012;73(7):e899–905.
28. Bearden CE et al. Patterns of memory impairment in bipolar disorder and unipolar major depression. Psychiatry Res. 2006;142(2-3):139–50.
29. Ancin I et al. Sustained attention as a potential endophenotype for bipolar disorder. Acta Psychiatr Scand. 2010;122(3):235–45.
30. Schouws SN et al. Cognitive impairment in early and late bipolar disorder. Am J Geriatr Psychiatry. 2009;17(6):508–15.
31. Weisenbach SL et al. The double burden of age and disease on cognition and quality of life in bipolar disorder. Int J Geriatr Psychiatry. 2014;29(9):952–61.
32. Rosa AR et al. Clinical staging in bipolar disorder: focus on cognition and functioning. J Clin Psychiatry. 2014;75(5):e450–6.
33. Nehra R et al. Comparison of cognitive functions between first- and multi-episode bipolar affective disorders. J Affect Disord. 2006;93(1-3):185–92.
34. Depp CA et al. Short-term course of neuropsychological abilities in middle-aged and older adults with bipolar disorder. Bipolar Disord. 2008;10(6):684–90.
35. Normala I, Abdul HA, Azlin B, Nik Ruzyanei NJ, Hazli Z, Shah SA. Executive function and attention span in euthymic patients with bipolar 1 disorder.pdf> Med J Malaysia. 2010;65:199–203.
36. Depp CA et al. Neurocognitive impairment in middle-aged and older adults with bipolar disorder: comparison to schizophrenia and normal comparison subjects. J Affect Disord. 2007;101:201–9.
37. Gildengers AG et al. Cognition in older adults with bipolar disorder versus major depressive disorder. Bipolar Disord. 2012;14(2):198–205.
38. Martino DJ et al. Cognitive and motor features in elderly people with bipolar disorder. J Affect Disord. 2008;105(1–3):291–5.
39. Zaki N et al. Cognitive functions in euthymic patients with bipolar II disorder and their correlation with the clinical profile. Middle East Curr Psychiatry. 2014;21(3):139–47.
40. Bombin I et al. Neuropsychological evidence for abnormal neurodevelopment associated with early-onset psychoses. Psychol Med. 2013;43(04):757–68.
41. Bearden CE et al. Sources of declarative memory impairment in bipolar disorder: mnemonic processes and clinical features. J Psychiatr Res. 2006;40(1):47–58.
42. Schouws SN et al. Cognitive functioning in elderly patients with early onset bipolar disorder. Int J Geriatr Psychiatry. 2007;22(9):856–61.
43. Santos JL et al. A five-year follow-up study of neurocognitive functioning in bipolar disorder. Bipolar Disord. 2014;16(7):722–31.
44. Martino DJ et al. Toward the identification of neurocognitive subtypes in euthymic patients with bipolar disorder. J Affect Disord. 2014;167:118–24.
45. Hellvin T et al. Neurocognitive functioning in patients recently diagnosed with bipolar disorder. Bipolar Disord. 2012;14(3):227–38.
46. Gualtieri CT, Johnson LG. Age-related cognitive decline in patients with mood disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(4):962–7.
47. Gruber S, Rosso IM, Yurgelun-Todd D. Neuropsychological performance predicts clinical recovery in bipolar patients. J Affect Disord. 2008;105(1):253–60.
48. Strejilevich SA, Martino DJ. Cognitive function in adulthood and elderly euthymic bipolar patients: a comparison to test models of cognitive evolution. J Affect Disord. 2013;150(3):1188-91. doi:10.1016/j.jad.2013.05.012.
49. Gildengers AG et al. Two-year course of cognitive function and instrumental activities of daily living in older adults with bipolar disorder: evidence for neuroprogression? Psychol Med. 2013;43(4):801–11.
50. Kozicky JM et al. Cognitive change in the year after a first manic episode: association between clinical outcome and cognitive performance early in the course of bipolar I disorder. J Clin Psychiatry. 2014;75(6):e587–93.
51. Gunning-Dixon FM et al. Executive dysfunction in elderly bipolar manic patients. Am J Geriatr Psychiatry. 2008;16(6):506–12.
52. Lewandowski KE et al. Age as a predictor of cognitive decline in bipolar disorder. Am J Geriatr Psychiatry. 2014;22(12):1462–8.
53. Rej S et al. Neuroimaging and neurocognitive abnormalities associated with bipolar disorder in old age. Int J Geriatr Psychiatry. 2014;29(4):421–7.
54. Schouws SN et al. Self-reported cognitive complaints in elderly bipolar patients. Am J Geriatr Psychiatry. 2012;20(8):700–6.
55. Stern Y. Cognitive reserve. Neuropsychologia. 2009;47(10):2015–28.
56. Gildengers AG et al. Cognitive functioning and instrumental activities of daily living in late-life bipolar disorder. Am J Geriatr Psychiatry. 2007;15(2):174–9.
57. Czepielewski et al. Verbal episodic memory along the course of schizophrenia and bipolar disorder: a new perspective. Eur Neuropsychopharmacol. 2015;25(2):169-75.
58. Ryan et al. Differential executive functioning performance by phase of bipolar disorder. Bipolar Disord. 2012;14(5):527-36.
59. Gama CS et al. Staging and neuroprogression in bipolar disorder: a systematic review of the literature. Rev Bras Psiquiatr. 2013;35(1):70–4.
60. Frodl T, Amico F. Is there an association between peripheral immune markers and structural/functional neuroimaging findings? Prog Neuro-Psychopharmacol Biol Psychiatry. 2013;3(48):295–303.
61. Kapczinski F et al. Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother. 2009;9(7):957–66.
62. Nehra R et al. Neuro-cognitive functioning in unaffected siblings of patients with bipolar disorder: comparison with bipolar patients and healthy controls. Indian J Psychiatry. 2014;56(3):283–8.
63. Bora E, Yucel M, Pantelis C. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord. 2009;113(1-2):1–20.
64. Nehra R et al. Neuro-cognitive functioning in unaffected siblings of patients with bipolar disorder: comparison with bipolar patients and healthy controls. Indian J Psychiatry. 2014;56(3):283.
65. Tabarés-Seisdedos R et al. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up. J Affect Disord. 2008;109(3):286–99.
66. Sibille E. Molecular aging of the brain, neuroplasticity, and vulnerability to depression and other brain-related disorders. Dialogues Clin Neurosci. 2013;15(1):53.
67. Kauer-Sant’Anna M, Kapczinski F, Andreazza AC, Bond DJ, Lam RW, Young LT, et al. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol. 2009;12(4):12.
68. Grande I et al. Staging bipolar disorder: clinical, biochemical, and functional correlates. Acta Psychiatr Scand. 2014;129(6):437–44.
69. Robinson L, Ferrier N. Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disord. 2006;8(2):103–16.
70. López-Jaramillo C et al. Lithium treatment effects on the neuropsychological functioning of patients with bipolar I disorder. J Clin Psychiatry. 2010;71(8):1055–60.
71. Harvey PD et al. Cognitive functioning and acute sedative effects of risperidone and quetiapine in patients with stable bipolar I disorder: a randomized, double-blind, crossover study. J Clin Psychiatry. 2007;68(8):1186–94.
72. Hirschfeld R et al. Screening for bipolar disorder in the community. J Clin Psychiatry. 2003;64(1):53–9.
73. Turner EH. Publication bias, with a focus on psychiatry: causes and solutions. CNS Drugs. 2013;27(6):457–68.
74. Baltes PB. Longitudinal and cross-sectional sequences in the study of age and generation effects. Hum Dev. 1968;11(3):145–71.